Nunn Jason Raleigh (CIK 1444319) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-10-14). Recent activity: Buy ZBIO (63,158 shares), Sell RGLS (62,500 shares), Buy RGLS (62,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-14 | Zenas BioPharma, Inc. (ZBIO) | Director | Buy | 63,158 | $1.2M |
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) | Director | Sell | 62,500 | $0 |
| 2025-04-30 | Regulus Therapeutics Inc. (RGLS) | Director | Buy | 62,500 | $0 |
Source: SEC Form 4 filings · as of 2025-10-14